[ad_1]
Melbourne, Australia, January 21, 2019 / PRNewswire / – Monash University biospectroscopists have obtained a US patent for diagnostic technology that they hope someday will help doctors diagnose and treat patients much faster than current methods of pathology.
Scientists have developed a new device that can quickly detect blood in minutes to detect a range of pathogens that cause the disease, which could speed up the process of diagnosing and treating the disease or l & # 39; infection.
From a blood sample or other body fluids, it can potentially diagnose serious illnesses in an hour, including a bacterial or fungal infection, HIV, hepatitis and diabetes. It can also create a complete blood profile indicating the general health of a patient simultaneously.
The technology consists of a small spectrometer that uses infrared light to badyze pathogens that cause diseases in the blood. Each pathogen has a unique chemical footprint and it is from this footprint that a diagnosis can be made. The portable device weighs about seven kilograms and is powered by a small battery.
A US patent has been issued for the technology ( https://www.monash.edu/science/news/current/us-grants-monash-scientists-patent-for-a-diagnostic-technique-that-could-deliver-a-more-accurate-test-for- malaria ) The last year for its ability to detect malaria, but the second patent has been extended to the latter (( http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%&F=1&P=1&P=1. = PN / 10145839) to detect all pathogens in the blood. The patents, which have been licensed to Biotech Resources (Aust) Pty. Ltd. (BTR) https://www.btrdiagnostics.com/ are the first of their kind to use spectroscopy to quantify pathogens in the blood. BTR will market the product.
The diagnostic technique was designed by the co-inventors, Dr. Philip HeraudProfessor Bayden Wood and Dr David Perez-Guaita, from the biospectroscopy center of Monash University[[[[https://www.monash.edu/science/cfb] in Melbourne, Australia.
The team is currently testing patients for the detection of bacterial and fungal pathogens in the blood that cause fatal infectious bacterial sepsis.
"This technology represents a paradigm shift for disease diagnosis and has been recognized with patent rights," said Professor Wood.
"This means that doctors can sort a patient faster than ever before – directly to the point of care – current techniques may take several days to return a diagnosis – but this technique can provide an initial diagnosis within one hour, allowing patients with infections or life-threatening diseases be treated without delay. "
The next step is to market and refine the technology. The researchers hope the device can be approved for use in hospitals and in the field in the next three to four years.
SOURCE Monash University
Source link
